LYFE Capital
Overview
LYFE Capital is a life science investment firm.
Investment Focus
- Established product foundation
- Need for capital to accelerate growth in Greater China
- Focus on biotechnology, pharmaceutical, medical device, diagnostic, healthcare service, and digital health sectors
Portfolio Companies
Reach LYFE Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about LYFE Capital
What sectors does LYFE Capital invest in?
LYFE Capital invests in Healthcare, Healthcare Services, Digital Health, Pharmaceuticals, Medical Devices and Diagnostics, and is based in Shanghai, Shanghai, China. LYFE Capital is listed as a vc in the ConnectSafely investor database.
What stage does LYFE Capital invest at?
LYFE Capital backs companies at Seed, Series A, Series B, Growth, Late Stage and Pre-IPO, writing cheques of 1M - 50M.
Which regions does LYFE Capital invest in?
LYFE Capital invests across United States, Japan, Singapore, China and South Korea.
Who are the partners at LYFE Capital?
Team members listed for LYFE Capital include Roy Xu (CFO) and Jack Chen (Managing Partner).
What companies has LYFE Capital invested in?
LYFE Capital's portfolio includes Noah Medical, Edge Medical, ST Pharm, Profound Bio, Bora Pharmaceuticals, Brightech, Jeisis Medical and Fong's Engineering.
How do I contact LYFE Capital?
LYFE Capital's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
